Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Klein

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Human Antibodies and Hybridomas|April 1, 1991
Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell linesG J Jochems, M R Klein, R Jordens, et al.
Cellular Immunology|September 1, 1992
Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cellsR J Bende, G J Jochems, T H Frame, et al.
AIDS Research and Human Retroviruses|March 20, 1997
Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individualsM R Klein, J Veenstra, A M Holwerda, et al.
The Journal of Infectious Diseases|June 1, 1994
Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell countsI P Keet, A Krol, M R Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDSS H van der Burg, M R Klein, O Pontesilli, et al.
The Journal of Infectious Diseases|December 8, 1998
Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identificationC Berger, D van Baarle, M J Kersten, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
The Journal of Infectious Diseases|March 10, 2001
HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosisM R Klein, S M Smith, A S Hammond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Human CD8+ CTL specific for the mycobacterial major secreted antigen 85AS M Smith, R Brookes, M R Klein, et al.
Immunological Reviews|August 1, 1994
Changing virus-host interactions in the course of HIV-1 infectionF Miedema, L Meyaard, M Koot, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Human Antibodies and Hybridomas|April 1, 1991
Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell linesG J Jochems, M R Klein, R Jordens, et al.
Cellular Immunology|September 1, 1992
Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cellsR J Bende, G J Jochems, T H Frame, et al.
AIDS Research and Human Retroviruses|March 20, 1997
Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individualsM R Klein, J Veenstra, A M Holwerda, et al.
The Journal of Infectious Diseases|June 1, 1994
Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell countsI P Keet, A Krol, M R Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDSS H van der Burg, M R Klein, O Pontesilli, et al.
The Journal of Infectious Diseases|December 8, 1998
Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identificationC Berger, D van Baarle, M J Kersten, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
The Journal of Infectious Diseases|March 10, 2001
HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosisM R Klein, S M Smith, A S Hammond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Human CD8+ CTL specific for the mycobacterial major secreted antigen 85AS M Smith, R Brookes, M R Klein, et al.
Immunological Reviews|August 1, 1994
Changing virus-host interactions in the course of HIV-1 infectionF Miedema, L Meyaard, M Koot, et al.
Pageof 5